UNSPSC 51241501: Boric acid/sodium borate

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class OP500. This VA Drug Class (OP500) classifies this compound as belonging to the group EYE WASHES/LUBRICANTS.

UNSPSC 51241501 Boric acid/sodium borate is a Commodity code that in recent state and local procurement covers generic multi-source pharmaceuticals and over-the-counter products distributed through cooperative purchasing agreements. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, recently issued an RFP seeking manufacturers to supply comprehensive pharmaceutical and OTC product lines with specific National Drug Codes (NDC), SKUs, UPCs, and packaging configurations to participating state and local government facilities across multiple states including Oregon. Vendors must certify compliance with current Good Manufacturing Practices (cGMP) and the Drug Supply Chain Security Act (DSCSA), maintain contractual relationships with at least two of three authorized wholesalers (AmerisourceBergen Drug Corporation/Cencora, Cardinal Health 110 and 112, and Morris & Dickson Co., LLC) with chargeback systems in place, and demonstrate pricing flexibility through flat price, net price formats, or WAC-minus structures. All products must be available in the marketplace by May 15, 2026, and possess expiration dates of at least one year from manufacture with a minimum six-month shelf life. Required insurance includes commercial general liability of $5,000,000 per occurrence, network security and privacy liability of $2,000,000, and professional liability of $2,000,000.

MMCAP's RFP, posted January 20, 2026 with responses due March 26, 2026, represents a cooperative purchasing vehicle serving multiple jurisdictions rather than a single issuing body. The evaluation weightings emphasize price competitiveness (75 percent) alongside fixed pricing (10 percent), EDI capability (5 percent), and administrative compliance requirements (5 percent each). The contract term spans two years for new responders with optional extensions at MMCAP's sole discretion, with incumbent responders' amendments aligning through June 30, 2028. MMCAP reserves the right to make sole, dual, or multi-awards based on therapeutic considerations and member-specific needs. Vendors should anticipate a 3 percent administrative fee on all contract purchases and performance penalties ranging from $200 to $1,500 per violation for late reporting, missed onboarding timelines, or improper class-of-trade denials. Specific award values or budget ranges are not disclosed in the solicitation materials.